Natural & Non-toxic CBD
The Blackhawk Difference
The FDA has expressed concerns over potential damage to the liver when consuming CBD’s in oral supplements.
Blackhawk Science inc. hold a license for a formulation (patent pending) which, when combined with orally taken CBD’s, protects the liver from damage.
The marketplace for the use of orally administered CBD’s has grown exponentially over the last few years and continues to exhibit huge growth potential. The market is expected to reach over 2 Billion Dollars in sales in North America in the coming year with a projected compound annual growth rate of 32% to 2024, with health benefits of CBD oil being one of the major drivers of the market.